marijuana stocks news

OrganiGram Holdings Inc. (OGRMF)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Feb 28, 2015 Nov 30, 2014 Jul 31, 2014 Apr 30, 2014
Total Revenue 142   12   –   –  
Cost of Revenue 27 6 – –
Gross Profit 115   6   –   –  
Operating Expenses
Research Development – – – –
Selling General and Administrative 539 723 177 24
Non Recurring – – – 2
Others – – – –
Total Operating Expenses – – – –
Operating Income or Loss (423) (718) (177) (26)
Income from Continuing Operations
Total Other Income/Expenses Net – – 5 –
Earnings Before Interest And Taxes (423) (718) (172) (25)
Interest Expense 23 – – –
Income Before Tax (446) (718) (172) (25)
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops (446) (718) (172) (25)
Non-recurring Events
Discontinued Operations – – – –
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (446) (718) (172) (25)
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (446) (718) (172) (25)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$TAUG to Present at Cannabis Investor Webcast on April 9, 2015

Tauriga Sciences, Inc. to Present at Cannabis Investor Webcast on April 9,…

Scoop: Shopify And ParcelPal To Integrate For Cannabis Delivery In Canada

As originally reported by Benzinga Within the next few weeks, users of Shopify Inc.…

Aurora Cannabis Inc. (ACBFF) & CanniMed Therapeutics Inc. (CMED.TO) File Offer Documents for Previously Announced Friendly Acquisition

Aurora Cannabis and CanniMed Therapeutics File Offer Documents for Previously Announced Friendly…

INSYS Therapeutics (INSY) Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) Oral Solution

INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) Oral Solution…